LRCX
45
6
CMG
67
3
NSC
57
7
MDLZ
36
2
AXP
69
3
JWN
42
2
SLG
66
2
LB
41
7
ADSK
68
2
PFG
42
3
EXC
56
2
MRK
27
5
WAT
53
6
KEY
43
3
M
25
5
CB
51
3
ILMN
37
5
K
57
4
ORLY
60
7
THC
55
-4
LRCX
45
6
CMG
67
3
NSC
57
7
MDLZ
36
2
AXP
69
3
JWN
42
2
SLG
66
2
LB
41
7
ADSK
68
2
PFG
42
3
EXC
56
2
MRK
27
5
WAT
53
6
KEY
43
3
M
25
5
CB
51
3
ILMN
37
5
K
57
4
ORLY
60
7
THC
55
-4
Financhill
Back

Corvus Pharmaceuticals Vs. Atara Biotherapeutics Industry Stock Comparison

Buy
58

CRVS
Corvus Pharmaceuticals

Last Price:
9.19
Seasonality Move:
-3.9%
Sell
30

ATRA
Atara Biotherapeutics

Last Price:
11.11
Seasonality Move:
16.06%
Buy
58
Corvus Pharmaceuticals (CRVS) is a Buy

Is Corvus Pharmaceuticals a Buy, Sell or Hold?

  • The current Corvus Pharmaceuticals [CRVS] share price is $8.94. The Score for CRVS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • CRVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Atara Biotherapeutics (ATRA) is a Sell

Is Atara Biotherapeutics a Buy, Sell or Hold?

  • The current Atara Biotherapeutics [ATRA] share price is $10.61. The Score for ATRA is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • ATRA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRVS Stock Price Chart

What is Corvus Pharmaceuticals's stock price today?

  • The Corvus Pharmaceuticals share price today is $8.94
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRVS is experiencing buying pressure, which is a positive indicator for future bullish movement.

ATRA Stock Price Chart

What is Atara Biotherapeutics's stock price today?

  • The Atara Biotherapeutics share price today is $10.61
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATRA is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRVS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.4 Buy
Relative Strength Index (14 RSI): 60.34 Buy
Chaikin Money Flow: 638494 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.94 - 9.14) Buy
Bollinger Bands (100): (2.78 - 7.48) Buy

ATRA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.66 Buy
Relative Strength Index (14 RSI): 51.14 Buy
Chaikin Money Flow: 52286 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.88 - 11.82) Buy
Bollinger Bands (100): (7.39 - 10.51) Buy

CRVS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.53 Buy
20-day SMA: 8.78 Buy
50-day SMA: 7.1 Buy
200-day SMA: 3.54 Buy
8-day EMA: 8.6 Buy
20-day EMA: 8.41 Buy
50-day EMA: 7.24 Buy
200-day EMA: 4.34 Buy

ATRA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.8 Sell
20-day SMA: 10.7 Sell
50-day SMA: 9.19 Buy
200-day SMA: 12.49 Sell
8-day EMA: 11.22 Sell
20-day EMA: 10.76 Sell
50-day EMA: 9.82 Buy
200-day EMA: 14.75 Sell

Corvus Pharmaceuticals Earnings Growth & CRVS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and an increase next year of $0.46 per share.

Atara Biotherapeutics Earnings Growth & ATRA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $13.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $56.86 per share, and a decrease next year of $3.35 per share.

Corvus Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Atara Biotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):